Welcome to our dedicated page for American Well SEC filings (Ticker: AMWL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Well Corporation filings document the company’s SaaS-based technology-enabled healthcare platform, operating results, customer agreements, governance, and equity-compensation structure. Its Form 8-K filings include earnings reports for quarterly and annual periods, material definitive agreements, board changes, and related exhibit disclosures.
AMWL filings also describe commercial arrangements tied to digital care delivery, including the company’s operation of a white-labeled platform under the LiveHealth Online brand for Elevance Health and related clinical-provider access through Online Care Group. Proxy materials cover director elections, executive compensation, equity awards, stockholder voting matters, and board governance for the public company.
Cosgrove Delos M. reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Delos M. Cosgrove received an equity grant in the form of restricted stock units. The award covers 14,501 shares of Class A Common Stock at no cash cost and increases his direct holdings to 71,193 shares. The RSUs vest on the earlier of the day immediately preceding the first annual stockholders’ meeting following the grant date or the first anniversary of the grant date, linking compensation to continued board service.
Webb Robert Thomas reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Robert Thomas Webb received an equity grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. The award was granted at no cash cost to him and is compensation-related, not an open-market purchase.
These restricted stock units vest on the earlier of the day immediately preceding the first annual stockholder meeting following the grant date or the first anniversary of the grant date. After this grant, Webb directly holds 72,559 shares of Class A Common Stock, indicating the transaction is modest relative to his total reported holdings.
Ross Derek reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Derek Ross received a grant of 14,501 shares of Class A Common Stock in the form of restricted stock units at no cash cost on June 16, 2026. These units vest on the earlier of the day before the first annual stockholder meeting after the grant or the first anniversary of the grant date. After this award, Ross directly holds 71,183 shares.
Goldwasser Rivka reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Rivka Goldwasser received a grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. These units were awarded at no cash cost per share and increase her direct holdings to 105,861 shares following the transaction.
The restricted stock units vest on the earlier of the day immediately preceding the first annual meeting of stockholders after the grant date, or the first anniversary of the grant date, tying the award to both time and the company’s annual meeting cycle.
Schlegel Stephen J. reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Stephen J. Schlegel received an equity grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. The grant was awarded at no cash cost per share as part of his compensation. Following this award, Schlegel directly holds 69,054 shares of Class A Common Stock. The restricted stock units vest on the earlier of the day immediately before the first annual stockholders’ meeting after the grant date or the first anniversary of the grant date, tying the award to his continued board service.
Jackson Deborah C reported acquisition or exercise transactions in this Form 4 filing.
American Well Corp director Deborah C. Jackson received an equity grant of 14,501 shares of Class A Common Stock in the form of restricted stock units. The award was granted at no cash cost per share and is part of her director compensation.
The restricted stock units vest on the earlier of the day immediately before the first annual meeting of stockholders following the grant date or the first anniversary of the grant date. After this grant, Jackson directly holds 53,633 shares of Class A Common Stock.
American Well Corp director Stephen J. Schlegel reported an open-market sale of 9,750 shares of Class A Common Stock at $8.764 per share. The transaction occurred on June 11, 2026 and was executed under a Rule 10b5-1 trading plan.
According to the filing, the plan was adopted on February 17, 2026 and the sale was made to cover tax liabilities from the vesting and settlement of restricted stock units on June 11, 2026. After this sale, Schlegel directly holds 54,553 shares of American Well Corp Class A Common Stock.
American Well Corp’s Chief Financial Officer Mark Hirschhorn reported an automatic sale of 10,761 shares of Class A Common Stock on June 1, 2026 at $9.74 per share. According to the disclosure, this "sell to cover" transaction was executed solely to pay taxes arising from the vesting and settlement of restricted stock units on that date and did not represent a discretionary trade. Following the sale, Hirschhorn directly holds 243,238 shares.
American Well Corp President, International Phyllis Gotlib reported an automatic share sale primarily to cover taxes on vested equity. On June 1, 2026, she sold 3,573 shares of Class A Common Stock at $9.74 per share in an open-market sale designated as a “sell to cover” transaction. After this sale, she held 159,431 shares directly and 114,920 shares indirectly through her husband. The footnote explains that the transaction was executed automatically to satisfy tax liabilities from restricted stock unit vesting and did not represent a discretionary trade.